Jan Novák

3.9k citations
63 papers · 1.6k indexed · 1 hit paper · h-index 19
Topics
Immune Cell Function and Interaction (18 papers)T-cell and B-cell Immunology (15 papers)Diabetes and associated disorders (11 papers)

In The Last Decade

Jan Novák

57 papers receiving 1.5k citations

Hit Papers

Ibrutinib plus obinutuzumab versus chlorambucil plus obin...20182026202020232018100200300

Peers

Jan Novák
Comparison fields: 5 of 81
  • Immunology 805
  • Genetics 487
  • Pathology and Forensic Medicine 440
  • Molecular Biology 238
  • Genetics 237
Replace C A Alper with:
C A Alper United States
Koiti Inokuchi Japan
Marco Chilosi Italy
J L Preud'homme France
Nathalie Balandraud France
R. J. Winchester United States
Mehran Ghaderi Sweden
Neelufar Mozaffarian United States
Jill Giles‐Komar United States
Ingrid Simonitsch Austria
Jan Novák relative to C A Alper United States C A Alper's profile →
Citations per field
00.5×10×13×
C A Alper · 1×
Citations per year

Countries citing papers authored by Jan Novák

Since Specialization
Citations

This map shows the geographic impact of Jan Novák's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Novák with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Novák more than expected).

Fields of papers citing papers by Jan Novák

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Novák. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Novák. The network helps show where Jan Novák may publish in the future.

Co-authorship network of co-authors of Jan Novák

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Novák. A scholar is included among the top collaborators of Jan Novák based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Novák. Jan Novák is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 15
4 1
5 15
6
Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trialbreakdown →
380
7 2
8 64
9 52
10 28
11 45
12 22
13 47
14 28
15 11
16 4
17 43
18 132
19
Prognostický význam imunohistochemického stanovení p53 ve tkáni povrchových nádorů močového měchýře
0
20 37

About Jan Novák

Jan Novák is a scholar working on Genetics, Immunology and Ophthalmology, having authored 63 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (18 papers), T-cell and B-cell Immunology (15 papers) and Diabetes and associated disorders (11 papers). The work is most often cited by research in Genetics (487 citations), Immunology (805 citations) and Pathology and Forensic Medicine (440 citations). Jan Novák has collaborated with scholars based in Czechia, United States and France. Frequent co-authors include Agnès Lehuen, Lucie Beaudoin, Lucie Nováková, Thibault Griseri, Tomáš Kozák, Véronique Laloux, Bruno Lucas, Martin Šimkovič, Carol Moreno and Fatih Demırkan. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026